Val Gene Romberg
Directeur/Bestuurslid bij Wuhan Zhongyuan Ruide Biological Products Co., Ltd.
Profiel
Val Gene Romberg is currently a Director at Wuhan Zhongyuan Ruide Biological Products Co., Ltd.
and CSL Behring Holdings Ltd.
Previously, he held positions as the Chief Executive Officer at Kedrion SpA and Kedrion Biopharma, Inc. He also served as the Co-Managing Director at CSL Behring Holdings GmbH and as the Executive Vice President-Manufacturing & Planning at CSL Behring LLC.
Additionally, he worked as a Principal at Centeon LLC.
Mr. Romberg completed his undergraduate degree at the University of Michigan.
Actieve functies van Val Gene Romberg
Bedrijven | Functie | Begin |
---|---|---|
Wuhan Zhongyuan Ruide Biological Products Co., Ltd.
Wuhan Zhongyuan Ruide Biological Products Co., Ltd. BiotechnologyHealth Technology Wuhan Zhongyuan Ruide Biological Products Co., Ltd. engages in the research and development, manufacture, and sale of biological products and blood products. The company was founded on on June 11, 2010 and is headquartered in Wuhan, China. | Directeur/Bestuurslid | - |
CSL Behring Holdings Ltd.
CSL Behring Holdings Ltd. Financial ConglomeratesFinance Part of CSL Ltd., CSL Behring Holdings Ltd. provides investment services. The company is based in Haywards Heath, UK. CSL Behring Holdings was founded in 1995. | Directeur/Bestuurslid | 15-06-2015 |
Eerdere bekende functies van Val Gene Romberg
Bedrijven | Functie | Einde |
---|---|---|
Kedrion Biopharma, Inc.
Kedrion Biopharma, Inc. Medical/Nursing ServicesHealth Services Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ. | Algemeen Directeur | - |
Kedrion SpA
Kedrion SpA Medical/Nursing ServicesHealth Services Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy. | Algemeen Directeur | - |
Centeon LLC | Corporate Officer/Principal | - |
CSL Behring Holdings GmbH
CSL Behring Holdings GmbH Financial ConglomeratesFinance Part of CSL Ltd., CSL Behring Holdings GmbH is a German company that functions as an investment holding company. The company is based in Marburg, Germany. The CEOs are Val Gene Romberg, Berthold Suesser. The company was founded in 2014. | Algemeen Directeur | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Val Gene Romberg
University of Michigan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Centeon LLC | |
Wuhan Zhongyuan Ruide Biological Products Co., Ltd.
Wuhan Zhongyuan Ruide Biological Products Co., Ltd. BiotechnologyHealth Technology Wuhan Zhongyuan Ruide Biological Products Co., Ltd. engages in the research and development, manufacture, and sale of biological products and blood products. The company was founded on on June 11, 2010 and is headquartered in Wuhan, China. | Health Technology |
CSL Behring Holdings GmbH
CSL Behring Holdings GmbH Financial ConglomeratesFinance Part of CSL Ltd., CSL Behring Holdings GmbH is a German company that functions as an investment holding company. The company is based in Marburg, Germany. The CEOs are Val Gene Romberg, Berthold Suesser. The company was founded in 2014. | Finance |
CSL Behring Holdings Ltd.
CSL Behring Holdings Ltd. Financial ConglomeratesFinance Part of CSL Ltd., CSL Behring Holdings Ltd. provides investment services. The company is based in Haywards Heath, UK. CSL Behring Holdings was founded in 1995. | Finance |
Kedrion SpA
Kedrion SpA Medical/Nursing ServicesHealth Services Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy. | Health Services |
Kedrion Biopharma, Inc.
Kedrion Biopharma, Inc. Medical/Nursing ServicesHealth Services Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ. | Health Services |